Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells
1999
How daunorubicin kills leukemia cells
publication
Evidence: moderate
Author Information
Author(s): Côme M-G, Skladanowski A, Larsen A K, Laurent G
Primary Institution: Institut Claudius-Régaud
Hypothesis
Can daunorubicin induce cell death in both sensitive and multidrug-resistant HL-60 cells through different mechanisms?
Conclusion
Daunorubicin can induce cell death through a dual mechanism in both sensitive and multidrug-resistant leukemia cells.
Supporting Evidence
- Daunorubicin induced rapid apoptosis in HL-60 cells at low concentrations.
- HL-60/Vinc cells showed delayed cell death at higher concentrations of daunorubicin.
- The study suggests that morphological changes may help evaluate treatment efficacy in leukemia patients.
Takeaway
This study found that a cancer drug called daunorubicin can kill leukemia cells in two different ways, depending on the type of cell.
Methodology
The study compared cell death processes in a human AML cell line and a multidrug-resistant subline at varying doses of daunorubicin.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website